BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13875044)

  • 1. Vascular lesions of the placenta of possible immunogenic origin in erythroblastosis fetalis.
    BURSTEIN RH; BLUMENTHAL HT
    Am J Obstet Gynecol; 1962 Apr; 83():1062-8. PubMed ID: 13875044
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal microcirculation of abnormal human placenta. II. Scanning electron microscopy of placental vascular casts from fetus with severe erythroblastosis fetalis.
    Lee MM; Yeh MN
    Am J Obstet Gynecol; 1986 May; 154(5):1139-46. PubMed ID: 2422939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of human placental growth with observations on the placenta in erythroblastosis foetalis.
    CRAWFORD JM
    J Obstet Gynaecol Br Emp; 1959 Dec; 66():885-96. PubMed ID: 13812713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Placental villi in pregnancy toxemias and fetal erythroblastosis in the fluorescent microscopy picture].
    BECKER V; BLEYL U
    Virchows Arch Pathol Anat Physiol Klin Med; 1961; 334():516-27. PubMed ID: 13866369
    [No Abstract]   [Full Text] [Related]  

  • 5. [Placentography in feto-maternal iso-immunization caused by the Rhesus factor].
    PALLIEZ R; DELECOUR M; SAVARY J; VITSE M; MONNIER JC
    Bull Fed Soc Gynecol Obstet Lang Fr; 1961; 13():395-8. PubMed ID: 14483370
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative histo- and immunopathological study of the placenta in diabetes mellitus and in erythroblastosis fetalis.
    BURSTEIN R; BERNS AW; HIRATA Y; BLUMENTHAL HT
    Am J Obstet Gynecol; 1963 May; 86():66-76. PubMed ID: 14017205
    [No Abstract]   [Full Text] [Related]  

  • 7. [Placenta-insufficiency. Morphometric researches on the model of Rhesus-placenta (author's transl)].
    Bender HG
    Arch Gynakol; 1974 May; 216(3):289-300. PubMed ID: 4407910
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histopathology of the brain in erythroblastosis fetalis].
    KUHL I
    Zentralbl Allg Pathol; 1954 Jul; 92(5-6):203-9. PubMed ID: 13227390
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution to the ultrastructure of human placental villi in fetal erythroblastosis].
    Widmaier G
    Arch Gynakol; 1969; 207(4):528-38. PubMed ID: 5819503
    [No Abstract]   [Full Text] [Related]  

  • 10. PLACENTAL MORPHOLOGY IN PATHOLOGIC GESTATIONS WITH OR WITHOUT TOXEMIA. OBSERVATIONS IN CASES OF DIABETES MELLITUS, HYDROPS FETALIS, TWIN PREGNANCY, PLACENTA PREVIA, AND HYDATIDIFORM MOLE.
    MAQUEO M; AZUELA JC; KARCHMER S; ARENAS JC
    Obstet Gynecol; 1965 Aug; 26():184-91. PubMed ID: 14315316
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental erythroblastosis fetalis in rabbits. II. The passage of blood group antigens and their specific isoantibodies across the placenta.
    KELLNER A; HEDAL EF
    J Exp Med; 1953 Jan; 97(1):51-60. PubMed ID: 13022861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [e1morphometric examinations of the placenta in morbus haemolyticus neonatorum (Mhn)].
    Estel C; Kadner J; Gerl D; Günther M; Ehrhardt G; Bretschneider E
    Zentralbl Gynakol; 1974 Mar; 96(13):402-5. PubMed ID: 4208563
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of erythroblastosis fetalis associated with congenital malformations, placental changes and renal disease in the mother.
    BISKIND LH; YOUNG AM
    Urol Cutaneous Rev; 1949 Jan; 53(1):10-2. PubMed ID: 18105805
    [No Abstract]   [Full Text] [Related]  

  • 14. Placental dimensions, cell size, and cell number in erythroblastosis fetalis.
    Vidyasagar D; Haworth JC
    Am J Obstet Gynecol; 1973 Jan; 115(2):267-70. PubMed ID: 4691845
    [No Abstract]   [Full Text] [Related]  

  • 15. [The placenta in hemolytic disease of the newborn].
    Busch W; Vogel M
    Z Geburtshilfe Perinatol; 1972 Feb; 176(1):17-28. PubMed ID: 5063269
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathology of the placenta. IV. Maturation disorders of the placenta under special clinical conditions].
    Emmrich P
    Zentralbl Pathol; 1991; 137(1):2-13. PubMed ID: 2059607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CORRELATION BETWEEN PLACENTAL ALTERATIONS AND THE PRODUCT IN ERYTHROBLASTOSIS FETALIS].
    CALDERONMARQUEZ JJ; MAQUEOTOPETE M; TORRES I
    Ginecol Obstet Mex; 1963; 18():373-82. PubMed ID: 14083087
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigations on the vascular system of the placenta. I. General introduction and the fetal vascular system.
    ARTS NF
    Am J Obstet Gynecol; 1961 Jul; 82():147-58. PubMed ID: 13684581
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic and pancreatic lesions in fetal erythroblastosis].
    EGGIMANN P
    Ann Paediatr; 1949 Feb; 172(2):73-98. PubMed ID: 18114473
    [No Abstract]   [Full Text] [Related]  

  • 20. Lutein cysts of ovaries associated with erythroblastotic hydrops fetalis. Assay of gonadotropin in serum of Rh-sensitized women in latter stages of pregnancy.
    CHRISTIE RW
    Am J Clin Pathol; 1961 Dec; 36():518-23. PubMed ID: 13879303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.